Search

Search Constraints

You searched for: Author/Creator Comeau, Michael

Search Results

1. 712 SBT6290, a systemically administered Nectin-4-directed TLR8 ImmunoTAC (TM) therapeutic, is a potent human myeloid cell agonist for the treatment of Nectin-4-expressing tumors. (9th November 2020)

2. 712 SBT6290, a systemically administered Nectin-4-directed TLR8 ImmunoTAC (TM) therapeutic, is a potent human myeloid cell agonist for the treatment of Nectin-4-expressing tumors. (9th November 2020)

3. Clinical consensus document for fitting non-surgical transcutaneous bone conduction hearing devices to children. (1st July 2022)